PepGen (PEPG) Other financing activities (2023 - 2026)
PepGen (PEPG) posted Other financing activities of $7000.0 for Q1 2026, up 100.01% sequentially from -$107.8 million in Q4 2025.
Analysis
PepGen (PEPG) Other financing activities (2023 - 2026) Analysis & Trends
PepGen has reported Other financing activities for 4 years, with the latest figure at $7000.0 in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $299000.0 (changed N/A YoY) and the FY2025 annual result came in at $292000.0, down 99.62% from the prior year.
- Other financing activities climbed to $7000.0 in Q1 2026 per PEPG's latest filing, from -$107.8 million in the prior quarter.
- Over five years, Other financing activities peaked at $108.1 million in Q3 2025 and troughed at -$107.8 million in Q4 2025.
- A 4-year average of $11.1 million and a median of $85000.0 in 2023 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 59036.92% in 2024, down 59036.92% in 2024.
- Over 4 years, Other financing activities stood at $38000.0 in 2023, then surged by 202210.53% to $76.9 million in 2024, then plunged by 240.23% to -$107.8 million in 2025, then soared by 100.01% to $7000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $7000.0, -$107.8 million, and $108.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Sep 30, 2025 | 108.00 Mn |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2024 | 76.88 Mn |
| Dec 31, 2023 | 38,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 130,000.00 |